====== Gerald Evans ======

{{ ::34ad8f40-ef77-4975-ab1a-0b34620081ba_1_201_a-180x180.jpeg?150|}}

Dr. **Gerald Evans** is a Canadian physician and [[infectious diseases]] specialist based in Kingston, Ontario.

===== Career and Affiliations =====

==== Queen's University ====

Evans is the Chair of the Division of Infectious Diseases and a Professor in the Departments of Medicine, Biomedical & Molecular Sciences and Pathology & Molecular Medicine at [[Queen’s University]]. He was initially appointed to a faculty position at Queen’s in 1990.((//Evans | Department of Medicine | School of Medicine.// (2021, December 24). Wayback Machine; Queen’s University. https://archive.ph/45iGh))

==== Association of Medical Microbiology and Infectious Disease Canada ====

Evans was the President of the [[Association of Medical Microbiology and Infectious Disease Canada]] (AMMI Canada) from 2009-2011, and is currently the Editor-in-Chief of the Official Journal of the Association of Microbiology and Infectious Disease Canada.

He is also the former Chair of the Guidelines Committee of AMMI Canada.((//Evans | Department of Medicine | School of Medicine.// (2021, December 24). Wayback Machine; Queen’s University. https://archive.ph/45iGh))

==== Kingston Health Sciences Centre ====

Evans is an attending physician in Infectious Diseases at [[Kingston Health Sciences Centre]], [[Hotel Dieu Hospital]], and [[Providence Care Hospital]].((//Gerald Evans.// KHSC Kingston Health Sciences Centre. Retrieved May 4, 2022, from https://archive.ph/qElPx)) Dr. Evans has been Medical Director of Infection Prevention & Control at the facilities since 2011.

The facilities are funded through the [[University Hospitals Kingston Foundation]] by [[AmerisourceBergen]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Baxter]], [[pharmaceutical_companies:Bayer]], [[Bell]], [[BMO Financial Group]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Canadian Cancer Society]], [[CIBC]], [[Corus Entertainment]], [[Costco]], [[pharmaceutical_companies:Covidien]], [[General Electric]], [[IBM]], [[Imperial Oil]], [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Johnson & Johnson]], [[KPMG]], [[pharmaceutical_companies:LEO Pharma]], [[Loblaws]], [[Manulife Financial]], [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Novopharm]], [[pharmaceutical_companies:Ortho Biotech]], [[pharmaceutical_companies:Paladin Laboratories]], [[PepsiCo]], [[pharmaceutical_companies:Pfizer]], [[Queen's University]], [[RBC (Royal Bank of Canada)]], [[RBC Foundation]], [[Rogers Media]], [[Ronald McDonald House Charities]], [[pharmaceutical_companies:Sanofi]], [[Scotiabank]], [[Shoppers Drug Mart]], [[medical_technology_companies:St. Jude Medical]], [[Sun Life Financial]], [[TC Energy]], [[TD Bank Group]], and [[TELUS]].((//Recognizing Your Contribution.// Kingston University Hospital Foundation. Retrieved May 4, 2022, from https://web.archive.org/web/20220504073124/https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution))

==== Ontario Ministry of Health and Long-Term Care ====

Evans is the immediate past Chair of the Committee to Evaluate Drugs of the [[Ontario Ministry of Health and Long-Term Care]], the Ministry’s expert advisory committee on optimal drug utilization for the province of Ontario. He also serves as Chair of the Working Group on Drugs for Rare Diseases for the MOHLTC.

==== Institute for Clinical Evaluative Sciences ====

Evans is an Affiliate Scientist at the [[Institute for Clinical Evaluative Sciences]].((//Gerald Evans.// Institute for Clinical Evaluative Sciences. Retrieved May 4, 2022, from https://www.ices.on.ca/About-ICES/ICES-Scientists/E/Gerald-Evans/Bio))

==== Public Health Ontario ====

Evans is an Infection Prevention and Control (IPAC) consultant physician with [[Public Health Ontario]].

==== Ontario Health ====

Evans is a member of the [[Cancer Care Ontario]] subcommittee under [[Ontario Health]].((//Gerald Evans.// Institute for Clinical Evaluative Sciences. Retrieved May 4, 2022, from https://www.ices.on.ca/About-ICES/ICES-Scientists/E/Gerald-Evans/Bio))

==== Ontario Drug Policy Research Network ====

Evans is a co-investigator with the [[Ontario Drug Policy Research Network]] (ODPRN), hosted at [[St. Michael's Hospital]] in [[canada:ontario:Toronto]].((//Core Academic Unit Members.// Ontario Drug Policy Research Network. Retrieved May 3, 2022, from https://archive.ph/MRjGj))

==== Reformulary ====

Evans is a member of the Expert Committee for [[Reformulary]], an evidence-based list of drugs reviewed and recommended by the panel.((//Reformulary Expert Committee Members and Special Advisors.// DrugFinder. Retrieved May 4, 2022, from https://archive.ph/XLi9P))

==== Critical Care Canada forum ====

Evans has participated as a speaker at the [[Critical Care Canada Forum]], the official meeting of the [[Canadian Critical Care Society]].((//Dr. Gerald Evans.// Critical Care Canada Forum. Retrieved May 4, 2022, from https://archive.ph/bTAYs)) The Forum's 2021 webinars were sponsored by [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Paladin Laboratories]], and [[medical_technology_companies:Masimo]].((//Sponsored Webinars 2021.// Critical Care Canada Forum. Retrieved May 4, 2022, from https://criticalcarecanada.com/sponsored-webinars-2021/))

==== Canadian Lyme Disease Research Network ====

Evans is a co-applicant on a grant for the [[Canadian Lyme Disease Research Network]], the project formerly led by Dr. [[Kieran Moore]].((//Gerald Evans Bio.// Canadian Lyme Disease Research Network. Retrieved May 4, 2022, from https://archive.ph/MMqiw))

==== Ontario COVID-19 Science Advisory Table ====

Evans is a member of the [[Ontario COVID-19 Science Advisory Table]], including as a member of the Behavioural Science Working Group.((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/))

===== Research =====

==== COVID-19 ====

Evans received research funding from the [[Southeastern Ontario Academic Medical Organization]] (SOAMO) for "synthesis and preclinical testing of novel small molecule therapies for [[COVID‐19]]."((Evans, G. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220215130832/https://covid19-sciencetable.ca/wp-content/uploads/2020/07/Declaration-of-Interest_Science-Table_Gerald-Evans_20210827.pdf))

===== Relationship with Pharmaceutical Companies =====

Evans has received research funding from [[pharmaceutical_companies:Biocryst]].((Stiver, H. G., Evans, G. A., Aoki, F. Y., Allen, U. D., & Laverdière, M. (2015). //Guidance on The Use of Antiviral Drugs for Influenza in Acute Care Facilities in Canada, 2014-2015.// Canadian Journal of Infectious Diseases and Medical Microbiology, 26(1), e5–e8. https://doi.org/10.1155/2015/371840))